For many patients living with Failed Back Surgery Syndrome (FBSS), persistent pain after a spinal operation raises an important question: are other options still available? In carefully evaluated cases, biologic disc repair — specifically intra-annular fibrin injection — may help address residual annular tears that surgery did not resolve. Candidacy is determined individually, and outcomes vary.

What Is Failed Back Surgery Syndrome (FBSS)?

Failed Back Surgery Syndrome is a clinical term describing persistent or new back and/or leg pain that continues after spinal surgery, most commonly laminectomy or spinal fusion. It is not a single diagnosis but rather a collection of ongoing symptoms — pain, reduced mobility, radiating discomfort — that persist despite a prior surgical intervention.

Several underlying factors may contribute to FBSS:

• Incomplete Decompression: The initial procedure may not have fully relieved pressure on affected nerve roots.
• Scar Tissue (Epidural Fibrosis): Post-surgical scar tissue can form around nerve roots, causing ongoing irritation and pain.
• New or Recurrent Disc Problems: Adjacent disc segments may degenerate more rapidly after fusion — a condition known as adjacent segment disease — leading to new herniations or discogenic pain above or below the fused level.
• Diagnostic Mismatch: The original surgery may have targeted a structure that was not the true pain generator, leaving the actual source unaddressed.
• Residual Spinal Instability: Instability may persist or develop in areas adjacent to the surgical site.
• Nerve Injury: Direct nerve trauma during surgery can produce chronic neuropathic pain that is difficult to resolve.

Expert Take

Our clinical team frequently evaluates patients who arrive frustrated after multiple interventions. In many of these cases, advanced imaging and targeted diagnostics reveal persistent annular tears — a common post-surgical finding that traditional procedures may have left unresolved. Identifying that specific pain generator is the critical first step before recommending any additional treatment.

The Emotional and Physical Weight of Unresolved Pain

The toll of FBSS extends well beyond physical discomfort. Many patients describe a profound sense of disappointment and uncertainty after investing significant time and hope in a surgical solution. Persistent symptoms may include radiating leg pain, numbness, tingling, weakness, and disrupted sleep — all of which can severely limit daily activity and quality of life.

For those who underwent spinal fusion specifically, the frustration can be compounded. Fusion immobilizes a vertebral segment to create stability, but it can simultaneously increase mechanical stress on adjacent discs — potentially accelerating degeneration at those neighboring levels over time. Recovery from an initial lumbar fusion can require months of reduced activity, making the persistence of pain afterward especially difficult to process.

Understanding why symptoms persist is essential. In many FBSS cases, the residual pain source is discogenic — rooted in ongoing annular damage — rather than in the structures that surgery addressed. Recognizing this distinction opens the door to genuinely different treatment pathways.

Why Revision Surgery Is Often Not the Optimal Next Step

When initial surgery fails to provide relief, repeat surgery may seem like a logical next move. However, revision spinal procedures are generally more technically complex, carry elevated risks, and do not offer predictable improvement. Each additional operation introduces further scar tissue, making it more difficult to isolate and address the pain source accurately.

Elevated risks associated with revision surgery may include:

• Increased risk of infection and blood loss
• Higher likelihood of nerve injury compared with the initial procedure
• Extended recovery periods
• Greater potential for accelerating adjacent segment disease
• Risk of worsening chronic pain conditions

For these reasons, many spine specialists now recommend a thorough reassessment of pain generators before proceeding with revision surgery, particularly when disc pathology or unresolved annular tears are suspected contributors to ongoing symptoms. Exploring whether a non-surgical approach may help is a reasonable and prudent step.

A Different Approach: Targeting the Disc Itself

Advances in regenerative medicine have shifted the way some clinicians think about chronic discogenic pain — including pain that persists after surgery. Rather than removing or fusing spinal structures, biologic disc repair focuses on supporting the body’s own healing mechanisms within the damaged disc itself.

Traditional adjunct treatments — physical therapy, medication management, and epidural steroid injections — offer meaningful relief for many patients in the short term. However, a systematic review published in the American Family Physician found epidural steroid injections were not effective for chronic low back pain in a meaningful subset of patients, and for those who have already undergone surgery, these options may feel like familiar ground that has already been covered without lasting benefit. This is precisely the context in which biologic disc repair may offer a genuinely different path.

For a broader overview of where this treatment fits within the wider landscape of conservative options, see our guide: 5 Non-Surgical Disc Treatments for Chronic Back Pain.

Biologic Disc Repair: Intra-Annular Fibrin Injection Explained

Our clinical team specializes in intra-annular fibrin injection — a biologic disc treatment that targets the outer wall of the intervertebral disc, known as the annulus fibrosus. When the annulus tears, the inner disc material and inflammatory proteins may leak outward, irritating nearby nerve roots and generating significant pain. This mechanism can remain active even after a prior surgery that addressed a herniation or attempted to decompress the nerve.

The fibrin procedure involves precisely delivering a fibrin sealant into the damaged annular tissue under fluoroscopic guidance. Fibrin is a naturally occurring protein central to the body’s wound-healing cascade. Once placed, it functions as a biologic scaffold that may:

• Seal annular tears: Reducing leakage of inflammatory nucleus material into the epidural space.
• Dampen local inflammation: By containing the pain-generating proteins within the disc, the inflammatory stimulus to surrounding nerve roots may be reduced.
• Support tissue repair: The fibrin matrix creates a favorable environment for the body’s own reparative cells to engage with the damaged annular tissue over time.

This approach is particularly relevant for FBSS patients because it addresses a pathology — ongoing annular disruption — that surgery alone may not have resolved, or that may have developed at an adjacent level following fusion. Learn more about how annular injuries relate to chronic back pain: Annular Tears and Chronic Low Back Pain.

Who May Be a Candidate After FBSS?

Determining candidacy for intra-annular fibrin injection after failed back surgery requires a comprehensive, individualized evaluation. This treatment is most appropriate when ongoing pain is primarily discogenic in origin — meaning it is generated by one or more damaged intervertebral discs rather than by bony instability or unresolved spinal stenosis. Candidates are evaluated individually, and not every patient with FBSS will qualify.

Conditions that may make a patient worth evaluating include:

• Persistent Annular Tears: Tears in the disc’s outer wall that remain or develop after a previous surgery and are confirmed on advanced imaging.
• Degenerative Disc Disease: Ongoing disc degeneration that the prior surgery did not adequately address, or that has progressed since the operation.
• Adjacent Segment Disease: Degeneration or new annular damage at the disc levels immediately above or below a previous fusion.
• Confirmed Discogenic Pain Source: Diagnostic workup — including MRI and, in some cases, provocative discography — that identifies a specific disc as the primary pain generator.

Before any biologic treatment is considered, active infection, significant mechanical instability, and other contraindications must be ruled out through thorough clinical and imaging review. A detailed evaluation of your surgical history, current symptoms, and imaging findings guides our team’s recommendation. For a closer look at what the evaluation process involves, visit: Am I a Candidate for Biologic Disc Repair: The Evaluation Process.

Expert Take

Adjacent segment disease is one of the more common findings we encounter in post-fusion patients who present with new or worsening pain. In selected cases where MRI reveals active annular disruption at adjacent levels and discogenic pain is confirmed diagnostically, intra-annular fibrin injection offers a biologically targeted option worth discussing — one that avoids adding further surgical complexity to an already-operated spine.

What the Procedure Involves and What Recovery May Look Like

Intra-annular fibrin injection is performed as an outpatient procedure; in most cases patients return home the same day. The injection is delivered under imaging guidance to ensure precise placement within the affected disc. There is no incision, no general anesthesia requirement, and no implant hardware involved.

Following the procedure, a period of protected activity is recommended to allow the fibrin scaffold to integrate with the disc tissue. Our clinical team provides individualized guidance on activity progression, return to movement, and any adjunct rehabilitation that may support recovery. The timeline and scope of recovery vary from patient to patient depending on the number of discs treated, the degree of prior surgical change, and individual healing response.

The aim of biologic disc repair is not simply temporary symptom suppression, but meaningful, sustained improvement in function and quality of life. Many patients treated for post-surgical discogenic pain report improvement in their ability to perform everyday activities; individual results, however, are not guaranteed and depend on the specific clinical picture. For more on what recovery may involve, see: 5 Things to Know About Recovery After Spine Treatment.

Advantages of This Approach Compared with Revision Surgery

For patients already navigating the aftermath of one or more spinal operations, the prospect of additional surgery carries understandable concern. Biologic disc repair offers a number of distinct characteristics that distinguish it from revision surgical approaches:

• No new incisions or implants: The procedure does not add hardware or remove additional disc tissue.
• Outpatient setting: No hospital admission is required in most cases.
• Lower risk profile: Without the tissue disruption of open surgery, the risks of blood loss, infection, and new scar tissue formation are substantially reduced.
• Preservation of motion: Unlike fusion, the fibrin procedure does not eliminate movement at the treated segment.
• Targets the underlying biology: Rather than mechanically altering the spine, this approach works with the disc’s own repair mechanisms.

For a direct comparison with fusion-based approaches, see: Biologic Disc Repair vs. Spinal Fusion: A Head-to-Head Comparison.

Our Clinical Approach: Evaluation Before Recommendation

We recognize that patients living with FBSS have often endured a prolonged and discouraging path. Our process begins with listening — understanding the full arc of your symptoms, the procedures you have undergone, and what has and has not helped. From that foundation, we build a diagnostic picture using current imaging, clinical examination, and, where indicated, targeted diagnostic injections.

Our process includes:

1. Comprehensive History Review: A detailed account of your prior surgeries, imaging results, and current symptom pattern to understand your individual situation.
2. Advanced Diagnostics: MRI evaluation with attention to annular integrity, and provocative discography when needed to confirm the pain-generating disc or discs.
3. Individualized Treatment Planning: A recommendation developed specifically for your anatomy, surgical history, and clinical goals — not a one-size-fits-all protocol.
4. Minimally Invasive Procedure: When candidacy is confirmed, intra-annular fibrin injection is offered as a targeted, outpatient biologic treatment.
5. Post-Treatment Guidance: Ongoing clinical support to monitor healing, guide activity progression, and optimize your recovery trajectory.

If you are weighing your options and want to understand the questions worth asking before any further intervention, this resource may be helpful: 5 Questions to Ask Before Agreeing to Spine Surgery.

Frequently Asked Questions

Can biologic disc repair be performed on a spine that has already been fused?

In many cases, yes — particularly when the source of pain is an adjacent disc rather than the fused segment itself. Each case is evaluated individually based on imaging findings and clinical presentation. Our team reviews your surgical history carefully to determine whether the fibrin procedure is appropriate for your specific anatomy.

How is the pain source confirmed before treatment?

Confirmation typically involves MRI evaluation for annular pathology combined with a clinical assessment of symptom patterns. In cases where the pain source remains ambiguous, provocative discography may be used to identify which disc is generating the symptoms. We do not recommend treatment before the pain generator has been clearly identified.

Is this treatment an option if I have had multiple surgeries?

A history of multiple spinal surgeries does not automatically disqualify a patient from evaluation. However, extensive prior surgical changes, significant scar tissue, or mechanical instability may affect candidacy. A thorough evaluation is necessary to determine whether biologic disc repair is a reasonable option in the context of your surgical history.

What is the recovery timeline compared with revision surgery?

Because intra-annular fibrin injection is an outpatient procedure with no incision or implant, the initial recovery period is generally shorter than that associated with revision open surgery. Most patients return home the same day. The disc healing process unfolds over weeks to months; individual recovery timelines vary and are guided by our clinical team on a case-by-case basis.

Are outcomes guaranteed?

No. Outcomes from biologic disc repair vary by patient, the extent of disc damage, surgical history, and other individual factors. Many patients in whom discogenic pain is the confirmed pain source report meaningful improvement; however, results are never universal and candidacy is assessed individually. Our team presents realistic expectations as part of every consultation.